Skip to main content

CSS LLC/IL

Position in TVTX — Travere Therapeutics, Inc.

CIK 1103646 CHICAGO, IL

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$481,180
+$259,247 QoQ
Shares Held
8,470
+13.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#198
of 312 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Derivatives in TVTX

reported options exposure · as of Jun 30, 2022
CallValue
$121,150
CallShares
5,000
PutValue
$637,249
PutShares
26,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $23,782,728 across 16 Biotechnology names. TVTX ranks #6 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TVTX
Travere Therapeutics, Inc.
This page
8,470 $481,180

All Filings in TVTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $481,180 8,470
2026-03-31 $221,933 7,470
2022-09-30 $662,594 26,891
2022-06-30 $704,002 29,055
2022-06-30 $121,150 5,000
2022-06-30 $637,249 26,300
2022-03-31 $554,699 21,525
2021-12-31 $668,136 21,525
2021-12-31 $384,896 12,400
2021-09-30 $300,700 12,400
2021-09-30 $622,934 25,688
2021-09-30 $12,125 500
2021-06-30 $75,868 5,200
2021-06-30 $176,539 12,100
2021-06-30 $299,445 20,524
2021-03-31 $227,227 9,100
2021-03-31 $235,866 9,446